Navigation Links
MedImmune Expands Scientific and Engineering Leadership
Date:12/20/2007

oject management. In 1996, Dr. Stageman led the team that initiated the successful Phase 3 development of Faslodex(R) (fulvestrant). Later, as AZ vice president of biopharmaceutical strategy, he established a team that steered the organization's aggressive drive into biologics, including the acquisitions of both CAT and MedImmune. Dr. Stageman has served on several UK Research Council grant committees and recently served as a member of the Royal Society working party on pharmacogenetics. He is an honorary professor at the University of Manchester and holds both a bachelor of science degree in chemistry and a doctorate in physical chemistry from the University of Bristol.

Jon Green, vice president, business operations is responsible for developing and maintaining all operational, infrastructure and support activities at MedImmune's Cambridge site. Prior to joining CAT in 1992, he held a number of academic posts including on the Medical Research Council, Carshalton, and in the Department of Biochemistry at Imperial College London. Mr. Green holds a primary certification and a master's degree, both in molecular biology. He is a fellow of the Institute of Biology with chartered status.

With 14 years of experience at CAT, Jane Osbourn, Ph.D., currently serves as vice president, research, and acting head, oncology research for MedImmune's Cambridge operations. Previously, she has held a number of product and technology development posts within the organization. Dr. Osbourn completed a doctorate at the John Innes Centre for Plant Science Research in Norwich, followed by a British Heart Foundation Post doctoral fellowship at the Department of Medicine at Addenbrooke's Hospital in Cambridge. She obtained a first-class degree in natural sciences (biochemistry) from the University of Cambridge.

Paul Varley, Ph.D., currently vice president, development, Cambridge, joined CAT in 1998 as director of pharmaceutical sciences and was promoted to vice president o
'/>"/>

SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
4. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
7. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
8. Rohm and Haas Expands in India
9. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
10. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
11. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Hollywood, FL (PRWEB) , ... ... ... internet’s most-visited bodybuilding and fitness site and the largest online retailer of ... Supplement Awards. BPI Sports is up for 11 awards in the following ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... of its industry-defining contract lifecycle management solution, as well as announced the date ... increase the speed and ease of contract management tasks as well as enhancements ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing ... the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at 9:45am (ET) at Le ... of the Company’s presentation may be accessed via the investor relations section of the ...
(Date:8/3/2015)... ... August 03, 2015 , ... The U.S. Food and Drug ... Kybella is similar to deoxycholic acid, which occurs naturally in the body and helps ... to treat this area of the body. These are invasive procedures and very expensive ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... predicted to decline by 39 percent, according to market research compiled for the ... data from the U.S. Department of Labor, Bureau of Labor Statistics. As the ...
Breaking Medicine News(10 mins):Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Novatus Unveils Milestone Software Release 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3
... Dec. 17 HealthSouth,Corporation (NYSE: HLS ) today ... EST on Tuesday, Feb. 24, 2009, to discuss its results ... The conference call may ... 76626362. International callers should dial (973) 582-2847 and,give the same ...
... ATLANTA, Dec. 17, 2008, The AMERIGROUP Foundation announced ... Outreach worker at West End Medical Centers, by designating ... Ms. Roper has contributed significantly to the ... years of extensive neighborhood involvement. For the past ...
... those with pulmonary clots saw benefit, , , WEDNESDAY, Dec. ... the clot-dissolving drug tenecteplase (TKNase) to people with sudden ... a form of tissue plasminogen activator (tPA), didn,t work ... up on the idea. , "In specific situations, those ...
... 17 Human Pheromone,Sciences, Inc. (OTC Bulletin Board: EROX) ... Comprehensive Patent Application with the U.S. Patent and,Trademark Office ... with its origin in sea coral, which has significant ... positive social relationships,personal well-being and social attraction. , ...
... request of the presidential transition team, ideas on advancing ... today by the American College of Physicians (ACP). ... student members. It is the nation,s largest medical ... membership organization. , "ACP believes that it is essential ...
... leader in the planning and development of sustainable, social and ... Dr. Theresa Ramsey,s Center For Natural Healing to create OTP2 ... the focus of the collaboration - to provide consulting services ... , , OTP2 brings together ...
Cached Medicine News:Health News:HealthSouth Announces Date of 2008 Fourth Quarter and Year-End Earnings Conference Call 2Health News:Fredericka Roper of Atlanta Honored as 'Healthy Hero' By the AMERIGROUP Foundation 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 3Health News:HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 2Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 4
(Date:7/31/2015)... 31, 2015  Seeger Weiss LLP is reporting that on ... warning letter to C.R. Bard, the manufacturer of Inferior ... to correct violations the agency found at two of Bard,s ... the FDA cited them during Inspectional Observations that occurred on ... Tempe, AZ , location and on October 6, ...
(Date:7/31/2015)... 31, 2015  Boston Children,s Hospital physicians report ... printing of their anatomy before undergoing high-risk brain ... (abnormalities in the brain,s blood vessels) that posed ... in the Journal of Neurosurgery: Pediatrics , ... and synthetic resins to create custom, high-fidelity models ...
(Date:7/31/2015)... PORTLAND, Ore., July 31, 2015  Semler Scientific, Inc. ... and testing services to healthcare insurers and physician groups, ... June 30, 2015. "In the second ... over year revenue growth of 54%, quarter over quarter ... of the installed base of FloChec® units of 18%," ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... A number of costs associated with nonprescription drug ... and a half years. Certain material costs for plastic ... during this time, increasing packaging expenses. Advertising and marketing ... the majority of marketers reduced advertising costs in 2009, ...
... ERT (Nasdaq: ERES ) announced today ... 2010 on Thursday, November 4, 2010, after the market closes. ... at 5:00 PM EDT that day. For ... within the United States or 1-412-858-4600 when calling internationally. There ...
Cached Medicine Technology:Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods, According to Kline 2Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods, According to Kline 3ERT to Announce Third Quarter 2010 Results on November 4, 2010 2
... might just be the world's most versatile ... support, post-op/rehab support, or both, Flex is ... Accutrac™ ROM hinges control flexion and extension ... durability while being heat-moldable to accommodate changes ...
... The Drytex Adjustable Patella Donut is ... unique nylon core and polyester Lycra ... A trimable full-circumference donut provides for ... have neoprene based allergies or irritations. ...
... The cool version of the TROM ... range-of-motion and locking capabilities as the full ... warmer climates. The ease of use and ... a variety of protocols following major ligament ...
Provides range-of-motion control for both flexion and extension along with a drop lock feature...
Medicine Products: